Tag Archives: Donepezil

Dementia Medication De-Listed in France: Untruth, Half-Truth or Paternalistic News Blackout? (BBC News / Prescrire / ADI / Inside Health / JAMA Network Open)

Summary Early evening headlines yesterday, on BBC Radio 4 news, announced the “shocking” news that drugs for Alzheimer’s Disease / dementia had been de-listed in France. This story has not been followed-up, and appears to have been dropped quietly; although … Continue reading

Posted in Alzheimer’s Disease International (ADI), Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Review of Interventions Which May Potentially Delay Functional Decline in Persons With Dementia (BMJ Open)

Summary The authors examined 23 systematic reviews about the benefits of non-pharmacological, pharmacological and alternative therapies on activities of daily living (ADL) in people with dementia. Interventions thought to be effective (based on evidence sometimes judged to be “low quality”) … Continue reading

Posted in Commissioning, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Integrated Care, International, Management of Condition, Models of Dementia Care, Non-Pharmacological Treatments, Person-Centred Care, Personalisation, Pharmacological Treatments, Quick Insights, Systematic Reviews, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Dementia Drug Effective in Helping Avoid Transitions into Care Homes (MRC / BBC News / Lancet Neurology)

Summary Analysis of data from the DOMINO-AD Trial indicates that the drug Donepezil may be effective in avoiding care home admissions in more advanced cases of Alzheimer’s Disease. Discontinuation of donepezil appears to be associated with an increased risk of … Continue reading

Posted in Alzheimer's Society, BBC News, Commissioning, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, Patient Care Pathway, Patient Information, Person-Centred Care, Pharmacological Treatments, Practical Advice, Quick Insights, Scotland, Statistics, UK, Universal Interest | Tagged , , , , , , , , , , | Leave a comment

Pharmacological Treatments for Alzheimer’s Disease in Primary Care / Management of Cognitive Symptoms (DTB / Nursing Times)

Summary A Drug and Therapeutics Bulletin (DTB) article reviews the evidence concerning drugs prescribed for cognitive symptoms in Alzheimer’s Disease and discusses some issues in their prescription. Donepezil, galantamine and rivastigmine are licensed for mild to moderate Alzheimer’s Disease in … Continue reading

Posted in Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Management of Condition, Models of Dementia Care, NICE Guidelines, Pharmacological Treatments, Practical Advice, Quick Insights, UK | Tagged , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Assessment and Treatment of Dementia in Older Adults (NICE Eyes on Evidence)

Summary A quick review of the latest evidence regarding the assessment and treatment of dementia in older adults. This systematic review indicates that brief cognitive assessment tools can adequately detect early dementia. Whether interventions for mild cognitive impairment or early dementia … Continue reading

Posted in Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Models of Dementia Care, NICE Guidelines, Non-Pharmacological Treatments, Patient Care Pathway, Pharmacological Treatments, Quick Insights, Systematic Reviews, UK, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Fixed-Dose Combination of Memantine Extended Release and Donepezil for Alzheimer’s Disease: Licensing Application Submitted to FDA (Biospace Inc.)

Summary A new drug application has been submitted to the FDA (in the United States) for a fixed-dose combination of memantine extended release and donepezil for the treatment of moderate to severe Alzheimer’s Disease dementia. “Using the two drugs together … Continue reading

Posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Pharmacological Treatments, Quick Insights | Tagged , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Use of NICE Appraised Medicines in the NHS in England (HSCIC)

Summary The Health and Social Care Information Centre (HSCIC) estimates that national figures for Alzheimer’s Disease medicine use have been underestimated by around five per cent. Section 3.1 in this report relates to Alzheimer’s Disease medicines: donepezil, galantamine, rivastigmine and memantine. … Continue reading

Posted in For Doctors (mostly), For Researchers (mostly), National, NHS, Pharmacological Treatments, Quick Insights, Statistics, UK, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment